CRVS Corvus Pharmaceuticals, Inc.
$10.36▼ -0.86%
Healthcare
Other
Volume 28.4K
Avg Volume (10D) 1.04M
Key Metrics & Fundamentals
Market Cap
$871.49M
P/E Ratio
–
Div Yield
0.00%
52W Range
6.39 - 26.95
% vs 50 MA
-15.08%
% vs 200 MA
-27.29%
RSI-14
44.3
MACD Histogram
+0.1800
Beta (1Y vs SPY)
-0.60
Free Cash Flow
-$15.98M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$19.26M
COGS
–
Operating Exp
$19.30M
Operating Income
-$19.30M
EBIT
-$19.30M
Pretax Income
-$17.96M
Net Income
-$17.96M
EPS (Diluted)
-0.19
Price & Volume History
Loading chart…
Recent News
Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa
GlobeNewswire · Sep 30, 2026 4:05 PM ET
Corvus Pharmaceuticals (CRVS) Faces A Valuation Test, Is The Upside Already Priced In?
Simply Wall St. · Sep 25, 2026 10:09 AM ET
Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference
GlobeNewswire · Sep 3, 2026 8:30 AM ET
Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial
GlobeNewswire · Aug 27, 2026 7:30 AM ET
Corvus Pharmaceuticals (CRVS): This Clinical-Stage Drugmaker Just Got A Lot More Interesting
Insider Monkey · Aug 17, 2026 11:16 AM ET
Corvus Pharmaceuticals (CRVS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 14, 2026 11:42 AM ET
Corvus Pharmaceuticals Inc (CRVS) (Q2 2026) Earnings Call Highlights: Advancing Soquelitinib ...
GuruFocus.com · Aug 7, 2026 1:09 AM ET
Corvus Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 6, 2026 11:43 PM ET
Corvus Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat · Aug 6, 2026 8:03 PM ET
Corvus: Q2 Earnings Snapshot
Associated Press · Aug 6, 2026 4:36 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CRVS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.